Neurological benefits, clinical challenges, and neuropathologic promise of medical marijuana: a systematic review of cannabinoid effects in multiple sclerosis and experimental models of demyelination

HIGHLIGHTS

  • who: Victor Longoria and colleagues from the School of Natural Sciences, Kean University, Morris Ave, Union, NJ, USA have published the Article: Neurological Benefits, Clinical Challenges, and Neuropathologic Promise of Medical Marijuana: A Systematic Review of Cannabinoid Effects in Multiple Sclerosis and Experimental Models of Demyelination, in the Journal: Biomedicines 2022, 10, x FOR PEER REVIEW 2022, 10, x FOR PEER REVIEW Biomedicines Biomedicines 2022, 10, xof FOR PEER REVIEW 2022, 10, x FOR PEER REVIEW Table 7. Certainty evidence. Biomedicines of /2022/
  • what: This study evaluates the efficacy of medical marijuana in MS and . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?